BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

152 related articles for article (PubMed ID: 31667838)

  • 1. CXCL3 overexpression promotes the tumorigenic potential of uterine cervical cancer cells via the MAPK/ERK pathway.
    Qi YL; Li Y; Man XX; Sui HY; Zhao XL; Zhang PX; Qu XS; Zhang H; Wang BX; Li J; Qi SF; Jia LL; Luan HY; Zhang CB; Wang WQ
    J Cell Physiol; 2020 May; 235(5):4756-4765. PubMed ID: 31667838
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Chemokine CXCL3 mediates prostate cancer cells proliferation, migration and gene expression changes in an autocrine/paracrine fashion.
    Xin H; Cao Y; Shao ML; Zhang W; Zhang CB; Wang JT; Liang LC; Shao WW; Qi YL; Li Y; Zhang ZY; Yang Z; Sun YH; Zhang PX; Jia LL; Wang WQ
    Int Urol Nephrol; 2018 May; 50(5):861-868. PubMed ID: 29524043
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Elevated expression of CXCL3 in colon cancer promotes malignant behaviors of tumor cells in an ERK-dependent manner.
    Cheng Y; Yang X; Liang L; Xin H; Dong X; Li W; Li J; Guo X; Li Y; He J; Zhang C; Wang W
    BMC Cancer; 2023 Nov; 23(1):1162. PubMed ID: 38031087
    [TBL] [Abstract][Full Text] [Related]  

  • 4. High expression level of CXCL1/GROα is linked to advanced stage and worse survival in uterine cervical cancer and facilitates tumor cell malignant processes.
    Man X; Yang X; Wei Z; Tan Y; Li W; Jin H; Wang B
    BMC Cancer; 2022 Jun; 22(1):712. PubMed ID: 35764974
    [TBL] [Abstract][Full Text] [Related]  

  • 5. CXCL5, the upregulated chemokine in patients with uterine cervix cancer, in vivo and in vitro contributes to oncogenic potential of Hela uterine cervix cancer cells.
    Feng X; Zhang D; Li X; Ma S; Zhang C; Wang J; Li Y; Liang L; Zhang P; Qu Y; Zhang Z; Yang Z; Xiang Y; Zhang W; Wang S; Shao W; Wang W
    Biomed Pharmacother; 2018 Nov; 107():1496-1504. PubMed ID: 30257367
    [TBL] [Abstract][Full Text] [Related]  

  • 6. CXCL3 overexpression affects the malignant behavior of oral squamous cell carcinoma cells via the MAPK signaling pathway.
    Weng J; Ren Q; Li Z; Wang W; Guan J
    J Oral Pathol Med; 2021 Oct; 50(9):902-910. PubMed ID: 34392586
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Clinical significance and biological functions of chemokine CXCL3 in head and neck squamous cell carcinoma.
    Guan J; Weng J; Ren Q; Zhang C; Hu L; Deng W; Lu S; Dong X; Li W; Li Y; Wang W
    Biosci Rep; 2021 Dec; 41(12):. PubMed ID: 34870709
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Overexpression of CXCL3 can enhance the oncogenic potential of prostate cancer.
    Gui SL; Teng LC; Wang SQ; Liu S; Lin YL; Zhao XL; Liu L; Sui HY; Yang Y; Liang LC; Wang ML; Li XY; Cao Y; Li FY; Wang WQ
    Int Urol Nephrol; 2016 May; 48(5):701-9. PubMed ID: 26837773
    [TBL] [Abstract][Full Text] [Related]  

  • 9. High C-X-C motif chemokine 5 expression is associated with malignant phenotypes of prostate cancer cells via autocrine and paracrine pathways.
    Qi Y; Zhao W; Li M; Shao M; Wang J; Sui H; Yu H; Shao W; Gui S; Li J; Jia X; Jiang D; Li Y; Zhang P; Wang S; Wang W
    Int J Oncol; 2018 Jul; 53(1):358-370. PubMed ID: 29749439
    [TBL] [Abstract][Full Text] [Related]  

  • 10. PBK promotes aggressive phenotypes of cervical cancer through ERK/c-Myc signaling pathway.
    Ma H; Han F; Yan X; Qi G; Li Y; Li R; Yan S; Yuan C; Song K; Kong B
    J Cell Physiol; 2021 Apr; 236(4):2767-2781. PubMed ID: 33184870
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Diagnostic and prognostic values of C‑X‑C motif chemokine ligand 3 in patients with colon cancer.
    Ruan GT; Gong YZ; Liao XW; Wang S; Huang W; Wang XK; Zhu GZ; Liao C; Gao F
    Oncol Rep; 2019 Nov; 42(5):1996-2008. PubMed ID: 31545503
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Tumor-derived CXCL5 promotes human colorectal cancer metastasis through activation of the ERK/Elk-1/Snail and AKT/GSK3β/β-catenin pathways.
    Zhao J; Ou B; Han D; Wang P; Zong Y; Zhu C; Liu D; Zheng M; Sun J; Feng H; Lu A
    Mol Cancer; 2017 Mar; 16(1):70. PubMed ID: 28356111
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Evodiamine induces apoptosis and inhibits metastasis in MDA‑MB-231 human breast cancer cells in vitro and in vivo.
    Du J; Wang XF; Zhou QM; Zhang TL; Lu YY; Zhang H; Su SB
    Oncol Rep; 2013 Aug; 30(2):685-94. PubMed ID: 23708383
    [TBL] [Abstract][Full Text] [Related]  

  • 14. MiR-1258 promotes the apoptosis of cervical cancer cells by regulating the E2F1/P53 signaling pathway.
    Peng X; Zhang Y; Gao J; Cai C
    Exp Mol Pathol; 2020 Jun; 114():104368. PubMed ID: 31917289
    [TBL] [Abstract][Full Text] [Related]  

  • 15. LINC00511 knockdown prevents cervical cancer cell proliferation and reduces resistance to paclitaxel.
    Mao BD; Xu P; Xu P; Zhong Y; Ding WW; Meng QZ
    J Biosci; 2019 Jun; 44(2):. PubMed ID: 31180057
    [TBL] [Abstract][Full Text] [Related]  

  • 16. SULF2 promotes tumorigenesis and inhibits apoptosis of cervical cancer cells through the ERK/AKT signaling pathway.
    Jiang T; Chen ZH; Chen Z; Tan D
    Braz J Med Biol Res; 2020; 53(2):e8901. PubMed ID: 32049100
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Effects of CXCL3 on migration, invasion, proliferation and tube formation of trophoblast cells.
    Wang H; Wang T; Dai L; Cao W; Ye L; Gao L; Zhou B; Zhou R
    Placenta; 2018 Jun; 66():47-56. PubMed ID: 29884302
    [TBL] [Abstract][Full Text] [Related]  

  • 18. 5-Aminolevulinic acid photodynamic therapy in human cervical cancer via the activation of microRNA-143 and suppression of the Bcl-2/Bax signaling pathway.
    Guo Q; Dong B; Nan F; Guan D; Zhang Y
    Mol Med Rep; 2016 Jul; 14(1):544-50. PubMed ID: 27177038
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Mitofusin-2 Triggers Cervical Carcinoma Cell Hela Apoptosis via Mitochondrial Pathway in Mouse Model.
    Wang W; Liu X; Guo X; Quan H
    Cell Physiol Biochem; 2018; 46(1):69-81. PubMed ID: 29587277
    [TBL] [Abstract][Full Text] [Related]  

  • 20. CXC chemokines located in the 4q21 region are up-regulated in breast cancer.
    Bièche I; Chavey C; Andrieu C; Busson M; Vacher S; Le Corre L; Guinebretière JM; Burlinchon S; Lidereau R; Lazennec G
    Endocr Relat Cancer; 2007 Dec; 14(4):1039-52. PubMed ID: 18045955
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.